These results suggest that UBQLN2 dysregulation in neurons can drive NF-κB activation and cytosolic TDP-43 aggregation, supporting the concept of pathway convergence in ALS pathogenesis. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.